09/26/2023 | Press release | Distributed by Public on 09/26/2023 06:25
TALARIS THERAPEUTICS, INC. | |||||
Date: September 26, 2023 | By: |
/s/ Mary Kay Fenton |
|||
May Kay Fenton | |||||
Chief Financial Officer and Interim Chief Financial Officer |
Please select the service you want to use:
Smartlinks | Talaris Therapeutics Inc. | News | Health | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Issue of Shares and Capital Increase | Shareholder Meeting | Mergers and Acquisitions | Public Share Offering | Investment Funds | Lifestyle and Leisure | Leisure | Securities Issuers | Biotechnology and Medical Research Companies | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2023 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact